Merck launches US generics operation

Germany's Merck has established a US generics operation in New York -- Genpharm -- to ease access to the company on this side of the Atlantic. Robert J. Mauro, the former president of the troubled Able Laboratories in New Jersey, has been named president of Genpharm. "This will increase Merck's presence in the world's largest pharmaceutical market and will help solidify our position as the world's third-largest global generics company," said Hank Klakurka, CEO of the Merck Generics Group, a wholly owned business of Merck in Darmstadt, Germany.

- read this press release for more

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.